The Innovation Imperative: Tackling Antimicrobial Resistance
The modern antibiotic industry is at a critical crossroads. For decades, the continuous introduction of new antibacterial agents kept healthcare systems one step ahead of evolving pathogens. However, the discovery pipeline has slowed to a trickle, leading to a dangerous rise in multidrug-resistant organisms. This escalating crisis is fundamentally reshaping the financial priorities and clinical...
0 Commenti 0 condivisioni 14 Views 0 Anteprima
SocioMint https://sociomint.com